News

Altimmune Inc. (NASDAQ:ALT) saw its stock tumble by 37% after releasing topline data from its Phase 2b IMPACT trial ...
Altimmune (NASDAQ:ALT) lost ~64% in the premarket on Thursday after the company announced a mixed readout from a mid-stage ...
From the outset, the cast of the television series MASH was a solid ensemble of performers, led by Alan Alda, who ...
First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with statistically significant MASH resolution without worsening of fibrosis ...
Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...
The clinical-stage biopharmaceutical company reported that the trial met its primary endpoint, with up to 59.1% of participants achieving MASH resolution without worsening of fibrosis in an ...
Rivus Pharmaceuticals’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the ...
Nathaniel Lowe hit two home runs, James Wood and Luis Garcia Jr. hit back-to-back long balls in the fourth inning and the ...
Bathed in golden-hour light, the BeltLine, a pedestrian thoroughfare in Atlanta, had an enchanting atmosphere on the Thursday ...
Miley Cyrus performed a mash-up of "The Climb" and "We Can't Stop" for Spotify Billions Club Live concert in Paris, plus more ...
Paramount Pictures has acquired an original comedic pitch, inspired by the classic game MASH, from Emmy, Grammy, and Golden ...
Alex Garland and Danny Boyle have reunited for a follow-up to their 2002 classic. It has visual flair, terrifying adversaries ...